ArticleBiomolecules2026
Identification of an Optimal Gyroid Microarchitecture of 3D-Printed Hydroxyapatite Bone Substitutes for Vertical Bone Augmentation and Osteoconduction.
Article in Biomolecules, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
Triply periodic minimal surface (TPMS) microarchitectures combine low weight with high mechanical strength, and, in particular, G-gyroid-based microarchitectures represent a promising option for bone substitutes. Most studies on G-gyroid-based bone substitutes have reported only in silico or in vitro results, whereas in vivo data remain scarce and are generally limited to single G-gyroid microarchitectures. To identify the optimal G-gyroid microarchitecture for bone substitute applications, we compared three different G-gyroid designs with varying surface-to-surface distances to determine the most suitable architecture for osteoconduction and vertical bone augmentation. From a mechanical perspective, constructs with a wall-to-wall distance of 0.50 mm (gyroid05) exhibited higher compressive strength than those with distances of 0.80 mm (gyroid08) and 1.10 mm (gyroid11). In vivo assessment in a rabbit calvarial defect model demonstrated that defect bridging was improved by 44% with gyroid05 and by 40% with gyroid11 compared with gyroid08. In contrast, evaluation in a rabbit calvarial vertical bone augmentation model showed that bone height gain increased by 39% and 32% with gyroid08 and gyroid11, respectively, relative to gyroid05. Overall, the gyroid11 design demonstrated superior in vivo performance in defect bridging and bone augmentation, indicating that it may represent the most promising universal G-gyroid microarchitecture for bone substitutes.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.